| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
chromogranin A | 0.490 | 0.808 | 3.0E-02 |
|
disease | 0.320 | None | 1.000 | 1 | 1 | 2004 | 2006 | ||||||||
|
creatine kinase B | 0.608 | 0.615 | 0.22 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2012 | ||||||||
|
catenin delta 2 | 0.579 | 0.731 | 1.00 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2014 | ||||||||
|
G protein subunit beta 3 | 0.518 | 0.808 | 3.3E-11 |
|
disease | 0.320 | None | 1.000 | 1 | 1 | 2005 | 2007 | ||||||||
|
malate dehydrogenase 1 | 0.682 | 0.538 | 0.93 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2004 | 2009 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
disease | 0.320 | None | 0.500 | 1 | 0 | 2006 | 2007 | ||||||||
|
calcium/calmodulin dependent protein kinase II beta | 0.626 | 0.538 | 0.74 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2000 | 2010 | ||||||||
|
peroxiredoxin 6 | 0.572 | 0.731 | 4.8E-05 |
|
disease | 0.320 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
phospholipase A2 group IVB | 0.890 | 0.154 | 1.1E-40 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2005 | 2005 | ||||||||
|
DLG2 antisense RNA 1 | 0.861 | 0.077 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2003 | 2003 | |||||||||
|
microRNA 2682 | 0.805 | 0.154 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||||||
|
heterogeneous nuclear ribonucleoprotein A3 pseudogene 1 | 0.805 | 0.231 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2005 | 2005 | |||||||||
|
cyclin dependent kinase 5 | 0.495 | 0.846 | 0.14 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
cyclin dependent kinase inhibitor 1C | 0.456 | 0.846 | 0.82 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
aldo-keto reductase family 1 member A1 | 0.510 | 0.846 | 6.7E-07 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
CDC42 effector protein 3 | 0.722 | 0.423 | 0.19 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
growth arrest specific 2 like 1 | 0.861 | 0.077 | 0.83 |
|
disease | 0.310 | None | < 0.001 | 1 | 0 | 2011 | 2011 | ||||||||
|
insulin like growth factor 2 mRNA binding protein 2 | 0.588 | 0.615 | 0.24 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
chondroitin sulfate proteoglycan 5 | 0.861 | 0.115 | 5.6E-02 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2010 | 2013 | ||||||||
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 0.705 | 0.500 | 0.89 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
serine and arginine rich splicing factor 10 | 0.736 | 0.308 | 0.42 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
protein tyrosine phosphatase non-receptor type 21 | 0.890 | 0.192 | 2.2E-12 |
|
disease | 0.310 | None | 1.000 | 1 | 2 | 2011 | 2011 | ||||||||
|
checkpoint kinase 1 | 0.492 | 0.808 | 3.1E-08 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
follistatin like 1 | 0.541 | 0.808 | 0.89 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
kallikrein related peptidase 8 | 0.636 | 0.615 | 8.8E-05 |
|
disease | 0.310 | None | < 0.001 | 1 | 0 | 2008 | 2008 |